Journal of Clinical Research In HIV AIDS And Prevention

Journal of Clinical Research In HIV AIDS And Prevention

Journal of Clinical Research In HIV AIDS And Prevention

Open Access & Peer-Reviewed

Submit Manuscript

Aims and Scope


Journal of Clinical Research in HIV and AIDS and Prevention (ISSN: 2324-7339) is a prestigious, peer-reviewed, open access publication dedicated to showcasing cutting-edge research in the field of HIV/AIDS prevention, intervention, and treatment. Our prestigious platform provides a vital channel for top researchers and practitioners to share invaluable insights and experiences, cultivating a vibrant forum for the dissemination of cutting-edge scientific knowledge in the diverse field of HIV/AIDS research.


Scope and Focus of JCRHAP:

  • Research on HIV/AIDS prevention, intervention, and treatment strategies to enhance public health.
  • Studies in epidemiology, clinical medicine, biomedical sciences, and health policy related to HIV/AIDS.
  • Insights into pharmacoepidemiology, antiretroviral therapy, drug resistance, and vaccine development.
  • Examination of HIV co-infections, comorbidities, and emerging treatment approaches.
  • Exploration of psychosocial aspects, stigma reduction, and behavioral interventions.
  • Contributions to health economics, healthcare services, and policy development.
  • We encourage submissions that explore the use of artificial intelligence (AI) in disease diagnosis, treatment optimization, public health interventions, and predictive modeling.
     

Contributions from the following research areas are invited but not limited to the following branches:

  • Syphilis and HIV
  • Gonorrhea and HIV
  • HIV/AIDS
  • Antivirals
  • Economic impact
  • HIV vaccines
  • Viral Pathogenesis
  • Antiviral therapy
  • Virus replication
  • Vaccine research
  • AIDS Dementia Complex
  • Epidemiology of HIV
  • Highly Active Antiretroviral Therapy
  • Drug Research
  • HIV Status
  • Sex education
  • Circumcision and HIV
  • Prevention of HIV/AIDS
  • Transmission modes
  • HIV prevention strategies
  • HIV treatment guidelines
  • Pre-exposure prophylaxis (prep)
  • Post-exposure prophylaxis (PEP)
  • HIV drug resistance
  • HIV testing and diagnosis
  • Signs and symptoms
  • Viral load monitoring
  • CD4 count monitoring
  • Opportunistic infections in HIV/AIDS patients
  • Co-infections in HIV/AIDS patients
  • HIV-associated malignancies
  • Alternative medicine
  • HIV and mental health
  • HIV stigma and discrimination
  • HIV/AIDS and sexual health
  • HIV/AIDS and reproductive health
  • HIV/AIDS and maternal health
  • HIV/AIDS and pediatric care
  • HIV/AIDS and adolescent health
  • HIV/AIDS and aging
  • HIV/AIDS and nutrition
  • HIV/AIDS and substance abuse
  • HIV/AIDS and migration
  • HIV/AIDS and gender issues
  • HIV/AIDS and social determinants of health
  • HIV/AIDS and human rights
  • HIV/AIDS and community engagement
  • HIV/AIDS and healthcare disparities
  • HIV/AIDS and global health
  • HIV/AIDS and vaccine development
  • HIV/AIDS and cure research
  • HIV/AIDS and gene therapy
  • HIV/AIDS and immunotherapy
  • HIV/AIDS and immune activation
  • HIV/AIDS and immune reconstitution
  • HIV/AIDS and drug interactions
  • HIV/AIDS and adverse effects of medication
  • HIV/AIDS and pharmacokinetics
  • HIV/AIDS and drug development
  • HIV/AIDS and drug delivery systems
  • HIV/AIDS and personalized medicine
  • HIV/AIDS and precision medicine
  • HIV/AIDS and telemedicine
  • HIV/AIDS and mhealth
  • HIV/AIDS and ehealth
  • HIV/AIDS and artificial intelligence
  • HIV/AIDS and big data analytics
  • HIV/AIDS and data privacy
  • HIV/AIDS and data security
  • HIV/AIDS and patient-centered care

Journals By Subject

Life Sciences
Medical Sciences